MAHAFFY PATRICK J 4

What Happened

• Patrick J. Mahaffy, a director of Medicus Pharma Ltd. (MDCX), was granted/acquired 25,000 derivative shares as an award on March 30, 2026. The filing shows an acquisition price of $0.00, indicating a grant or compensatory award rather than an open-market purchase.

Key Details

• Transaction date: 2026-03-30; Filing date: 2026-04-01 (Form 4 accession 0000950142-26-001028).
• Transaction type/code: A (award/grant of a derivative security); Considered a derivative acquisition in the filing.
• Shares acquired: 25,000; Reported value: $0.00 (grant/award).
• Shares owned after the transaction: Not specified in the public filing.
• No 10b5-1 plan, tax-withholding, or other footnotes are listed in the information provided.

Context

• This was a compensatory award to a director (not an open-market purchase or sale). Such grants are commonly part of director compensation (e.g., restricted stock units or similar derivative awards) and do not necessarily reflect immediate buying or selling sentiment. The filing appears timely (reported two days after the transaction).